Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis. Journal for Immunotherapy of Cancer 6, 38 (2018). https://t.co/CFOp2kYCdN
2,036 followers
3,199 followers
Interesting data. Since we know that NY-ESO-1-specific CD8+ T cells up-regulate PD-1 expression, wonder if this should be combined with checkpoint inhibitors? Particularly in light of Checkmate 238 results. @sitcancer #Melanoma #melsm #immunoOncology https
440 followers
RT @sitcancer: #JITC Research: Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected #melanoma: a retrospective cohort analysis htt…
1,342 followers
RT @sitcancer: #JITC Research: Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected #melanoma: a retrospective cohort analysis htt…